Insights into Mechanisms of Pheochromocytomas and Paragangliomas Driven by Known or New Genetic Drivers
Pheochromocytomas and paragangliomas are rare tumors of neural crest origin. Their remarkable genetic diversity and high heritability have enabled discoveries of bona fide cancer driver genes with an impact on diagnosis and clinical management and have consistently shed light on new paradigms in can...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/18/4602 |
id |
doaj-d890b64f56e8460a8547d54f13ea7c3e |
---|---|
record_format |
Article |
spelling |
doaj-d890b64f56e8460a8547d54f13ea7c3e2021-09-25T23:49:33ZengMDPI AGCancers2072-66942021-09-01134602460210.3390/cancers13184602Insights into Mechanisms of Pheochromocytomas and Paragangliomas Driven by Known or New Genetic DriversShahida K. Flores0Cynthia M. Estrada-Zuniga1Keerthi Thallapureddy2Gustavo Armaiz-Peña3Patricia L. M. Dahia4Department of Medicine, University of Texas Health San Antonio, San Antonio, TX 78229, USADepartment of Medicine, University of Texas Health San Antonio, San Antonio, TX 78229, USADepartment of Medicine, University of Texas Health San Antonio, San Antonio, TX 78229, USADepartment of Medicine, University of Texas Health San Antonio, San Antonio, TX 78229, USADepartment of Medicine, University of Texas Health San Antonio, San Antonio, TX 78229, USAPheochromocytomas and paragangliomas are rare tumors of neural crest origin. Their remarkable genetic diversity and high heritability have enabled discoveries of bona fide cancer driver genes with an impact on diagnosis and clinical management and have consistently shed light on new paradigms in cancer. In this review, we explore unique mechanisms of pheochromocytoma and paraganglioma initiation and management by drawing from recent examples involving rare mutations of hypoxia-related genes <i>VHL, EPAS1</i> and <i>SDHB</i>, and of a poorly known susceptibility gene, <i>TMEM127.</i> These models expand our ability to predict variant pathogenicity, inform new functional domains, recognize environmental-gene connections, and highlight persistent therapeutic challenges for tumors with aggressive behavior.https://www.mdpi.com/2072-6694/13/18/4602pheochromocytomasparagangliomasmutationssusceptibility genesdriver mutationshereditary |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shahida K. Flores Cynthia M. Estrada-Zuniga Keerthi Thallapureddy Gustavo Armaiz-Peña Patricia L. M. Dahia |
spellingShingle |
Shahida K. Flores Cynthia M. Estrada-Zuniga Keerthi Thallapureddy Gustavo Armaiz-Peña Patricia L. M. Dahia Insights into Mechanisms of Pheochromocytomas and Paragangliomas Driven by Known or New Genetic Drivers Cancers pheochromocytomas paragangliomas mutations susceptibility genes driver mutations hereditary |
author_facet |
Shahida K. Flores Cynthia M. Estrada-Zuniga Keerthi Thallapureddy Gustavo Armaiz-Peña Patricia L. M. Dahia |
author_sort |
Shahida K. Flores |
title |
Insights into Mechanisms of Pheochromocytomas and Paragangliomas Driven by Known or New Genetic Drivers |
title_short |
Insights into Mechanisms of Pheochromocytomas and Paragangliomas Driven by Known or New Genetic Drivers |
title_full |
Insights into Mechanisms of Pheochromocytomas and Paragangliomas Driven by Known or New Genetic Drivers |
title_fullStr |
Insights into Mechanisms of Pheochromocytomas and Paragangliomas Driven by Known or New Genetic Drivers |
title_full_unstemmed |
Insights into Mechanisms of Pheochromocytomas and Paragangliomas Driven by Known or New Genetic Drivers |
title_sort |
insights into mechanisms of pheochromocytomas and paragangliomas driven by known or new genetic drivers |
publisher |
MDPI AG |
series |
Cancers |
issn |
2072-6694 |
publishDate |
2021-09-01 |
description |
Pheochromocytomas and paragangliomas are rare tumors of neural crest origin. Their remarkable genetic diversity and high heritability have enabled discoveries of bona fide cancer driver genes with an impact on diagnosis and clinical management and have consistently shed light on new paradigms in cancer. In this review, we explore unique mechanisms of pheochromocytoma and paraganglioma initiation and management by drawing from recent examples involving rare mutations of hypoxia-related genes <i>VHL, EPAS1</i> and <i>SDHB</i>, and of a poorly known susceptibility gene, <i>TMEM127.</i> These models expand our ability to predict variant pathogenicity, inform new functional domains, recognize environmental-gene connections, and highlight persistent therapeutic challenges for tumors with aggressive behavior. |
topic |
pheochromocytomas paragangliomas mutations susceptibility genes driver mutations hereditary |
url |
https://www.mdpi.com/2072-6694/13/18/4602 |
work_keys_str_mv |
AT shahidakflores insightsintomechanismsofpheochromocytomasandparagangliomasdrivenbyknownornewgeneticdrivers AT cynthiamestradazuniga insightsintomechanismsofpheochromocytomasandparagangliomasdrivenbyknownornewgeneticdrivers AT keerthithallapureddy insightsintomechanismsofpheochromocytomasandparagangliomasdrivenbyknownornewgeneticdrivers AT gustavoarmaizpena insightsintomechanismsofpheochromocytomasandparagangliomasdrivenbyknownornewgeneticdrivers AT patricialmdahia insightsintomechanismsofpheochromocytomasandparagangliomasdrivenbyknownornewgeneticdrivers |
_version_ |
1717367885134823424 |